Articles by Alan Shaw, PhD - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Alan Shaw, PhD

Alan Shaw, PhD


President and CEO of VaxInnate

Vaccines Incorporating Toll-Like Receptor Ligands
October 2, 2008

This article discusses the production process of the major influenza antigen, hemagglutinin (HA), by rDNA methods in E. coli.

ADVERTISEMENT

ADVERTISEMENT

Click here